Aveanna Healthcare Holdings Inc (AVAH)vsNovartis AG ADR (NVS)
AVAH
Aveanna Healthcare Holdings Inc
$6.55
-2.24%
HEALTHCARE · Cap: $1.42B
NVS
Novartis AG ADR
$147.85
+3.44%
HEALTHCARE · Cap: $282.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 2225% more annual revenue ($56.58B vs $2.43B). NVS leads profitability with a 23.9% profit margin vs 9.3%. AVAH trades at a lower P/E of 6.2x. AVAH earns a higher WallStSmart Score of 62/100 (C+).
AVAH
Buy62
out of 100
Grade: C+
NVS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+57.0%
Fair Value
$18.54
Current Price
$6.55
$11.99 discount
Margin of Safety
-52.5%
Fair Value
$109.60
Current Price
$147.85
$38.25 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Every $100 of equity generates 62 in profit
Earnings expanding 465.2% YoY
Revenue surging 27.4% year-over-year
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Expensive relative to growth rate
Grey zone — moderate risk
Revenue declined 0.7%
Earnings declined 9.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : AVAH
The strongest argument for AVAH centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 27.4% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bear Case : AVAH
The primary concerns for AVAH are Market Cap.
Bear Case : NVS
The primary concerns for NVS are PEG Ratio, Altman Z-Score, Revenue Growth.
Key Dynamics to Monitor
AVAH profiles as a growth stock while NVS is a declining play — different risk/reward profiles.
AVAH carries more volatility with a beta of 2.09 — expect wider price swings.
AVAH is growing revenue faster at 27.4% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
AVAH scores higher overall (62/100 vs 51/100) and 27.4% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aveanna Healthcare Holdings Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?